Kelley Shannon T — SEC insider filings
SEC reporting owner CIK 2034056. 9 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-08-19 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 7 filings — 4,789 shares, $1,966,798 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 1,077 shares @ $400.00 ($430,800) in MADRIGAL PHARMACEUTICALS, INC., filed 2026-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | 9 | — | 15 legs · 4,789 sh · $1,966,798 | 6 |
Insider filings — Kelley Shannon T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 1,077 @ $400 | EDGAR |
| 2026-08-20 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 664 @ $514.97 | EDGAR |
| 2026-03-06 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 4,017 @ $0 · Sale (S): 360 @ $431.94 · Grant/award (A): 5,022 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 263 @ $490.77 · Sale (S): 429 @ $501.40 | EDGAR |
| 2025-08-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 458 @ $358.66 · Sale (S): 126 @ $369.64 · Sale (S): 84 @ $370.06 · Sale (S): 84 @ $371.35 · Sale (S): 252 @ $372.44 · Sale (S): 68 @ $374.13 · +2 more | EDGAR |
| 2025-03-07 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 3,187 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 415 @ $335 | EDGAR |
| 2025-01-17 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 277 @ $273.41 | EDGAR |
| 2024-08-19 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 5,215 @ $0 · Grant/award (A): 7,820 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2034056 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs